<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJN</journal-id><journal-title-group><journal-title>Open Journal of Nursing</journal-title></journal-title-group><issn pub-type="epub">2162-5336</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojn.2019.912088</article-id><article-id pub-id-type="publisher-id">OJN-96920</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Correlates and Predictors of Health-Related Quality of Life among Patients with COPD: An Integrative Review
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nazih</surname><given-names>Abu Tabar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jafar</surname><given-names>Alasad Alshraideh</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Nursing Department, Ministry of Health, Amman, Jordan</addr-line></aff><aff id="aff2"><addr-line>School of Nursing, The University of Jordan, Amman, Jordan</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>12</month><year>2019</year></pub-date><volume>09</volume><issue>12</issue><fpage>1203</fpage><lpage>1225</lpage><history><date date-type="received"><day>25,</day>	<month>October</month>	<year>2019</year></date><date date-type="rev-recd"><day>6,</day>	<month>December</month>	<year>2019</year>	</date><date date-type="accepted"><day>9,</day>	<month>December</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Health-related quality of life is an important outcome variable with COPD patients. Impaired health-related quality of life among COPD patients is closely related to various factors. There are many factors that predict the HRQoL and the correlation with other important variables. Predictors of health-related quality of life were debatable in the literature. 
  Aim: This review aimed to describe the correlation with HRQoL and to explore the predictors of HRQoL among patients with COPD. 
  Methods: An integrative review method was conducted. A search protocol was conducted using EBSCO, Pubmed, CINAHL, Ovid, ProQuest, Cochrane, and Google Scholar databases up to October 1, 2019. 
  Results: The review results out of 30 articles that discuss the predictors of HRQoL and 22 articles that discuss the HRQoL correlations with other important variables. The HRQoL predictors are classified according to sociodemographic factors and clinical factors, and also, the correlation and prediction of HRQoL with anxiety, fatigue, and uncertainty. The results of this review showed controversies in predictors between the studies. The most retrieved predictors were age, educational level, comorbidities, socioeconomic status, FEV1% predicted, GOLD stages, and the number of hospitalizations. The variables of anxiety and fatigue were strongly correlated and predicted HRQoL. While uncertainty was not reported as a significant HRQoL predictor. 
  Conclusion: This review provides support about reliable predictors than unreliable one although some predictors still need further research in different races and cultures. Future research is needed to explore whether uncertainty can predict HRQoL among patients with COPD.
 
</p></abstract><kwd-group><kwd>HRQoL</kwd><kwd> COPD Integrative Review</kwd><kwd> Uncertainty</kwd><kwd> Anxiety</kwd><kwd> Fatigue</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Health-related quality of life (HRQoL) is an important outcome variable in many chronic diseases that have an impact on different aspects of a person’s life. Chronic Obstructive Pulmonary Disease (COPD) is one of those diseases in which HRQoL is affected and becoming a major environmental and public health issue [<xref ref-type="bibr" rid="scirp.96920-ref1">1</xref>]. Globally, COPD is considered a significant cause of mortality and morbidity across the modern world [<xref ref-type="bibr" rid="scirp.96920-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref3">3</xref>]. COPD is likely to increase in the coming years due to higher smoking prevalence, aging populations in many countries, and the spreading of environmental pollutants [<xref ref-type="bibr" rid="scirp.96920-ref4">4</xref>]. This made COPD the fourth leading cause of death and expected to become the third major cause of death by 2030 worldwide [<xref ref-type="bibr" rid="scirp.96920-ref5">5</xref>].</p><p>Chronic Obstructive Pulmonary Disease continues to be an important health burden [<xref ref-type="bibr" rid="scirp.96920-ref6">6</xref>]. COPD is a complex, multifaceted disease. It affects patients in many ways and results in significant impairment in their quality of life (QoL) [<xref ref-type="bibr" rid="scirp.96920-ref7">7</xref>]. It has a major impact on personal health status at large and HRQoL in specific. HRQoL was defined as a very broad concept referring to the quality of life that is directly related to health or illness [<xref ref-type="bibr" rid="scirp.96920-ref8">8</xref>]. HRQoL and QoL are used interchangeably [<xref ref-type="bibr" rid="scirp.96920-ref9">9</xref>]. HRQoL is composed of various aspects that involve physical, mental, emotional, and social wellbeing, which is completely different for each patient [<xref ref-type="bibr" rid="scirp.96920-ref10">10</xref>]. Impaired quality of life among COPD patients is closely related to the symptoms of shortness of breath, dyspnea, and impaired physical activities, like fatigue, and mental problems, like anxiety [<xref ref-type="bibr" rid="scirp.96920-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref12">12</xref>]. Therefore, the evaluation of HRQoL is an important outcome measure in assessing patients with COPD which informs about the causes of the burden of this disease and leads to improve patient management and develops policy decisions [<xref ref-type="bibr" rid="scirp.96920-ref13">13</xref>].</p><p>Furthermore, COPD is a distressing, difficult, and progressive condition that makes life miserable for many patients [<xref ref-type="bibr" rid="scirp.96920-ref14">14</xref>]. Thereby, COPD leads to a progressive worsening in HRQoL aspects among those patients who are having this disease [<xref ref-type="bibr" rid="scirp.96920-ref15">15</xref>]. Many studies reported an impairment of HRQoL among COPD patients which measured through using generic or specific HRQoL tools [<xref ref-type="bibr" rid="scirp.96920-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref18">18</xref>]. COPD is a complicated and comorbid disease that has many associated risk factors that can contribute to a significant impairment in functional, psychosocial, emotional and economic costs on the individual, community, and health services [<xref ref-type="bibr" rid="scirp.96920-ref1">1</xref>]. The associated factors lead to a gradual deterioration in the HRQoL, such as: severity of disease symptoms, the impact of symptoms on the subsequent reduction in daily activities, non-adherence management, and therapeutic noncompliance and psychosocial effect [<xref ref-type="bibr" rid="scirp.96920-ref6">6</xref>]. The interest in the associated factors contributing to HRQoL among patients with COPD is increasing [<xref ref-type="bibr" rid="scirp.96920-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref19">19</xref>]. The associated factors were classified in to sociodemographic and clinical variables, functional, psychological, and emotional among patients with COPD. Also, these factors are significant in discovering the main factors that predict the worsening in HRQoL level and explaining the correlation of HRQoL with other variables, specifically the level of anxiety, fatigue, uncertainty among those patients.</p><p>The integrative review aimed to identify and summarize relevant kinds of literature which are described HRQoL predictors and correlation of HRQoL with other variables specifically limited to perceived anxiety, level of fatigue and perceived uncertainty in patients with COPD. The findings of this review will contribute in adopting these predictors for updating clinical practice guidelines, institutional policy regarding the routine assessment and clinical intervention options with COPD patients, and improve knowledge among healthcare providers about the potential impact of psychosocial and physiological wellness on the health status of COPD patients. In addition to providing healthcare researchers with needed information that will help them in appraising and discussing the study results according to their study purpose.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Data Sources and Search Strategies</title><p>The integrative review was conducted to identify studies describe the predictors of HRQoL and correlate HRQoL with other specific variables among COPD patients. The online databases used in the literature review were PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), ProQuest, Medline, Google Scholar, SAGE Journals, Wiley online Library, Science Direct and EBSCOhost, Ovid journals, and Cochrane for systematic review articles. Literature searches were conducted for articles published up to October 1, 2019. The keywords used for searching in the online databases were COPD, pulmonary disease, anxiety, fatigue, uncertainty, HRQoL, QoL, and systematic review, and a combination thereof. The possible combinations of words were used using Boolean operators like AND or OR. Search in PubMed was conducted by utilizing a highly sensitive search filter technique. All the founded articles were screened for inclusion criteria. Each article retrieved in the search was independently assessed by the researcher in double methods. Researchers reviewed the titles and abstracts of each article. If the article indicated potential inclusion, the full-text of the article was assessed using the inclusion criteria. Any disagreement over the eligibility of particular articles was resolved through reviewing the article again in full or consulting another researcher.‎</p></sec><sec id="s2_2"><title>2.2. Inclusion and Exclusion Criteria</title><p>The articles met the following inclusion criteria were considered for full review: 1) discussed and reported at least two predictors of HRQoL or at least the correlations with one of following variables (i.e. anxiety, fatigue, uncertainty); 2) include HRQoL as outcome variable 3) the measurement of HRQoL was reported with valid and reliable tool; and 4) articles were provided in full text and published in English. Although excluding the publications written in another language than English will introduce a language bias, the English language is still generally perceived to be the universal language of science. The papers include overlapping pulmonary diseases like asthma, obstructive sleep apnea (OSA) or didn’t meet the inclusion criteria were excluded.</p></sec><sec id="s2_3"><title>2.3. Process of Identifying the Relevant Studies and Data Extraction</title><p>The potential articles were first screened for their titles and abstracts. Then, the relevant articles were reviewed in full for consideration of inclusion in the current review. The selection was according to fixed inclusion and exclusion criteria. The primary search in PubMed databases retrieved (80059) articles including research articles and systematic reviews and (44) articles through other resources. After combing three specific variables (anxiety, fatigue, and uncertainty) in the same search engine, (569) articles were identified. After removing duplicates (219) articles were identified. (350) records were excluded because they did not meet the inclusion criteria. From the reviewed titles and abstracts, (140) articles met our search criteria and were reviewed in full. Afterward, the selected articles were assessed for eligibility based on their full text. Of these, (52) final articles were selected. The relatively low number of articles was reflected in the scarcity of evidence around the study variables. After an in-depth review of the included articles, results were summarized according to the following two headings: predictors of HRQoL among COPD patients and the correlation between HRQoL and other specific variables. <xref ref-type="fig" rid="fig1">Figure 1</xref> demonstrates a flow chart for the selection of studies included in the literature review.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Health-related quality of life (HRQoL) was recognized as an important outcome when evaluating patients with COPD [<xref ref-type="bibr" rid="scirp.96920-ref20">20</xref>]. The fact that HRQoL is the result of the interaction of physical, psychological, and social factors can justify several predictors of HRQoL among COPD patients which were reported in the literature. These predictive factors were reported into five groups: demographic factors, comorbidity, factors related to the disease, psychological factors, and other related factors. HRQoL was comprised of several domains that involve physical, mental, and social wellbeing which significantly differs for each patient [<xref ref-type="bibr" rid="scirp.96920-ref10">10</xref>]. Impaired quality of life is closely related to shortness of breath, impaired physical activities, and mental problems such as; anxiety [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>]. COPD was found clearly correlated with fatigue, anxiety and reduced HRQoL. Therefore, HRQoL should be measured in tools that assess physical, social, and psychological domains. Currently, many HRQoL tools are available. Although there are generic HRQoL tools, which can be used to evaluate HRQoL in general for any population, there are disease-specific tools that can be used in patients with a certain disease experience [<xref ref-type="bibr" rid="scirp.96920-ref21">21</xref>]. So, the recommendation of using a disease-specific tool is needed to cover specific HRQoL aspects and patient-related experiences‎ [<xref ref-type="bibr" rid="scirp.96920-ref22">22</xref>].</p><p>In this review, the predictive factors were described into two Tables; <xref ref-type="table" rid="table1">Table 1</xref> presents the characteristics of the (30) studies analyzing factors predicting the HRQoL among patients with COPD and <xref ref-type="table" rid="table2">Table 2</xref> presents characteristics of (22) studies describing the correlations and predictive factors between HRQoL and other variables limited to (anxiety, fatigue, and uncertainty). So, to address the purpose of this integrative review, the findings were categorized under the following headings; predictors related to sociodemographic and clinical variables and correlate and predictors between HRQoL and other variables.</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of the studies analyzing factors predicting the HRQoL of patients with COPD (N = 30)</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >Author/Date</th><th align="center" valign="middle" >Study Sample</th><th align="center" valign="middle" >Study design</th><th align="center" valign="middle" >Data Collection Period</th><th align="center" valign="middle" >The instrument used to measure HRQoL</th><th align="center" valign="middle" >Predicting factor of HRQoL</th><th align="center" valign="middle" >Non predicting factor of HRQoL</th></tr></thead><tr><td align="center" valign="middle" >(Wu et al., 2019)</td><td align="center" valign="middle" >154 patients</td><td align="center" valign="middle" >A cross-sectional design</td><td align="center" valign="middle" >Between December 2016 and November 2017</td><td align="center" valign="middle" >CCQ</td><td align="center" valign="middle" >Age, Smoking status, Disease duration</td><td align="center" valign="middle" >Gender, marital status, employment status, BMI</td></tr><tr><td align="center" valign="middle" >(Shah, Shah, &amp; Kachoria, 2019)</td><td align="center" valign="middle" >60 patients</td><td align="center" valign="middle" >A prospective, cross-sectional study</td><td align="center" valign="middle" >From April to September 2017</td><td align="center" valign="middle" >SGRQ-C</td><td align="center" valign="middle" >Age, Nutrition, Smoking status, Alcohol intake, Socioeconomic status, Duration and severity of the disease, Presence of comorbidities, Type of COPD medication used, BMI</td><td align="center" valign="middle" >Sex, Education level, Employment status, Dietary habits</td></tr><tr><td align="center" valign="middle" >(Wytrychiewicz et al., 2019)</td><td align="center" valign="middle" >105 patients</td><td align="center" valign="middle" >Descriptive correlational study</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >Newley developed a tool which assesses eight aspects of illness potentially affecting QoL</td><td align="center" valign="middle" >Smoking status, BMI</td><td align="center" valign="middle" >Sex, Age, Marital status, Place of residence, Education, professional activity, Years since COPD diagnosis, Number of hospitalizations due to COPD</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >(Ghilley, Bhadoria, &amp; Pandit, 2018)</th><th align="center" valign="middle" >120 patients</th><th align="center" valign="middle" >Descriptive correlational</th><th align="center" valign="middle" >NA</th><th align="center" valign="middle" >SGRQ-C</th><th align="center" valign="middle" >FEV1/FVC (%) ratio</th><th align="center" valign="middle" >Age, BMI, Smoke pack/year, GOLD stage</th></tr></thead><tr><td align="center" valign="middle" >(Pati et al., 2018)</td><td align="center" valign="middle" >110 patients</td><td align="center" valign="middle" >The parallel mixed-method study design was</td><td align="center" valign="middle" >Between June and July 2014</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >Advanced age, Sex/female, More than two comorbidities, Low income, Family support</td><td align="center" valign="middle" >Occupation, Place of living</td></tr><tr><td align="center" valign="middle" >(Gaude &amp; Desai, 2018)</td><td align="center" valign="middle" >44 patients</td><td align="center" valign="middle" >Cross-sectional study</td><td align="center" valign="middle" >Between October 2016-November 2016</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >Age, Sex, Smoking, BMI, Socioeconomic status, Occupation type</td></tr><tr><td align="center" valign="middle" >(Farag, Sobh, Elsawy, &amp; Fahmy, 2018)</td><td align="center" valign="middle" >200 patients</td><td align="center" valign="middle" >A cross-sectional observational multicenter study</td><td align="center" valign="middle" >2 years</td><td align="center" valign="middle" >Arabic version of SGRQ.</td><td align="center" valign="middle" >FEV1 % Predicted, New, GOLD stage (ABCD), Comorbidity, particularly IHD, mMRC, Frequency of exacerbations per year, 6MWD</td><td align="center" valign="middle" >Age, BMI, GOLD Spirometrics staging, BODE index, FEV1/FVC (%), Smoking pack/year</td></tr><tr><td align="center" valign="middle" >(Brandl et al., 2018)</td><td align="center" valign="middle" >206 patients</td><td align="center" valign="middle" >A prospective patient cohort study</td><td align="center" valign="middle" >1 year and 4 months</td><td align="center" valign="middle" >Short-Form (SF-12) Health Survey Questionnaire</td><td align="center" valign="middle" >CAT, Number of, exacerbations (years), FEV1 % Predicted, Living alone</td><td align="center" valign="middle" >Age, Female gender, High educational level, Smoking, Number of medications, Disease duration</td></tr><tr><td align="center" valign="middle" >(Lee et al., 2017)</td><td align="center" valign="middle" >1264 patients</td><td align="center" valign="middle" >Prospective cohort</td><td align="center" valign="middle" >Between December 2011 and November 2015</td><td align="center" valign="middle" >SGRQ-C</td><td align="center" valign="middle" >Age, Education, No of comorbidities, 6MWD, Depression level, mMRC</td><td align="center" valign="middle" >Sex, BMI, Smoking status, FEV1% predicted</td></tr><tr><td align="center" valign="middle" >(Das, Bam, &amp; Ghimire, 2017)</td><td align="center" valign="middle" >81 patients</td><td align="center" valign="middle" >Descriptive observational cross-sectional</td><td align="center" valign="middle" >5 months</td><td align="center" valign="middle" >SGRQ-C</td><td align="center" valign="middle" >Smoking status</td><td align="center" valign="middle" >Age, Sex, Occupation, Education, Medications</td></tr><tr><td align="center" valign="middle" >(Cheruvu, Odhiambo, Mowls, Zullo, &amp; Gudina, 2016)</td><td align="center" valign="middle" >16602 patients</td><td align="center" valign="middle" >Telephone survey designed</td><td align="center" valign="middle" >From the 2011 and 2012</td><td align="center" valign="middle" >A newly developed tool which contains four HRQOL indicators</td><td align="center" valign="middle" >Sex, Age, Current smoker</td><td align="center" valign="middle" >Activity limitation, Unmarried, Level of education less than a college degree</td></tr><tr><td align="center" valign="middle" >(Kwon &amp; Kim, 2016)</td><td align="center" valign="middle" >2734 patients</td><td align="center" valign="middle" >Cross-sectional survey study</td><td align="center" valign="middle" >Between 2007-2012</td><td align="center" valign="middle" >EQ-5D</td><td align="center" valign="middle" >Age, Sex, Severity of COPD, Diabetes and hypertension comorbidities, Smoking status</td><td align="center" valign="middle" >Educational level, Income level</td></tr><tr><td align="center" valign="middle" >(Martinez et al., 2016)</td><td align="center" valign="middle" >4097 participants in the COPD Gene study and 1522 participants in SPIROMICS</td><td align="center" valign="middle" >a cross-sectional analysis of data from participants with COPD in two cohorts</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >Race, Smoking status, Moderate to severe dyspnea, exacerbation frequency, Presence of chronic bronchitis symptoms</td><td align="center" valign="middle" >Comorbidities, Activity level, Anxiety, and depression</td></tr><tr><td align="center" valign="middle" >(Sharma &amp; Joshi, 2015)</td><td align="center" valign="middle" >40 patients</td><td align="center" valign="middle" >A cross-sectional hospital-based study</td><td align="center" valign="middle" >From August 6, 2014, to August 7, 2014</td><td align="center" valign="middle" >a 56-item QOL questionnaire developed by the researcher</td><td align="center" valign="middle" >Age, Current smoker, Education level, Comorbidities, Hospital no of admission last three months, Need of drugs regularly</td><td align="center" valign="middle" >Sex, Marital status, Place of residence, Family type, Work status, Economic status, Duration of COPD, Smoking status</td></tr><tr><td align="center" valign="middle" >(Hong et al., 2015)</td><td align="center" valign="middle" >1178 patients</td><td align="center" valign="middle" >A cross-sectional survey analysis</td><td align="center" valign="middle" >Between the year of 2007 and 2010</td><td align="center" valign="middle" >EQ-5D</td><td align="center" valign="middle" >Old age, female gender, lower education level, many comorbid diseases, severe airflow obstruction (Gold stage)</td><td align="center" valign="middle" >BMI, ever-smoking</td></tr><tr><td align="center" valign="middle" >(Ekici, Bulcun, Karakoc, Senturk, &amp; Ekici, 2015)</td><td align="center" valign="middle" >62 patients</td><td align="center" valign="middle" >Descriptive correlational</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >FEV1 % Predicted, mMRC, Anxiety scores</td><td align="center" valign="middle" >Age, BMI, Total number of hospitalizations, Depression score</td></tr><tr><td align="center" valign="middle" >(Xiang et al., 2015)</td><td align="center" valign="middle" >142 COPD outpatients and 218 controlled COPD</td><td align="center" valign="middle" >Case-control study</td><td align="center" valign="middle" >May 1, 2004, to April 30, 2005.</td><td align="center" valign="middle" >MOS-SF-12 SGRQ</td><td align="center" valign="middle" >Marital status, Education, Religious belief, Life event in the past year</td><td align="center" valign="middle" >COPD severity, Living with others, Age/year, Sex/male, No of comorbidities, No of hospitalization last year ADLs</td></tr></tbody></table></table-wrap><table-wrap id="1_3"><table><tbody><thead><tr><th align="center" valign="middle" >(Bentsen, Miaskowski, &amp; Rust&#248;en, 2014)</th><th align="center" valign="middle" >100 patients</th><th align="center" valign="middle" >Cross-sectional study</th><th align="center" valign="middle" >NA</th><th align="center" valign="middle" >SGRQ</th><th align="center" valign="middle" >Age, Anxiety score</th><th align="center" valign="middle" >Number of comorbidities, Pain intensity, Depression score, Physical functions, GOLD Spirometrics staging, FEV1 % Predicted</th></tr></thead><tr><td align="center" valign="middle" >(Bonsaksen, Haukeland-Parker, Lerdal, &amp; Fagermoen, 2014)</td><td align="center" valign="middle" >127 patients</td><td align="center" valign="middle" >Prospective longitudinal design</td><td align="center" valign="middle" >12 months after course completion</td><td align="center" valign="middle" >Short Form 12, version 2 (SF-12v2), SF-36.</td><td align="center" valign="middle" >Work status, Illness perception</td><td align="center" valign="middle" >Age, Sex, Education, Physical activity, Self-efficacy</td></tr><tr><td align="center" valign="middle" >(Negi, Sarkar, Raval, Pandey, &amp; Das, 2014)</td><td align="center" valign="middle" >126 patients</td><td align="center" valign="middle" >A cross-sectional study</td><td align="center" valign="middle" >Between November 2011 and April 2012</td><td align="center" valign="middle" >Hindi version of SGRQ</td><td align="center" valign="middle" >BMI, FEV1% predicted, FEV1/FVC%, MRC Dyspnea grade, Education, GOLD stage</td><td align="center" valign="middle" >Age, Sex, Area of residence, Smoking index, Seasonal variation</td></tr><tr><td align="center" valign="middle" >(Raherison et al., 2014)</td><td align="center" valign="middle" >430 patients</td><td align="center" valign="middle" >A multicenter cross-sectional observational study</td><td align="center" valign="middle" >September 2009 to November 2010</td><td align="center" valign="middle" >SGRQ-C</td><td align="center" valign="middle" >MRC dyspnea score, Number of treatments, Age, Anxiety, FEV1% predicted</td><td align="center" valign="middle" >Gold stage, Age, FEV1/FVC, BOD Index, No of exacerbation</td></tr><tr><td align="center" valign="middle" >(Abu Hassan, Abd Aziz, Hassan, &amp; Hassan, 2014)</td><td align="center" valign="middle" >117 patients</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >January to June 2013</td><td align="center" valign="middle" >CCQ</td><td align="center" valign="middle" >Smoking status, No of hospital admission due to COPD</td><td align="center" valign="middle" >No of days warded</td></tr><tr><td align="center" valign="middle" >(Justine, Tahirah, &amp; Mohan, 2013)</td><td align="center" valign="middle" >100 patients</td><td align="center" valign="middle" >Cross-sectional correlational study</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SF-36 v2</td><td align="center" valign="middle" >Dyspnea score</td><td align="center" valign="middle" >Lung function</td></tr><tr><td align="center" valign="middle" >(Bentsen, Rokne, &amp; Wahl, 2013)</td><td align="center" valign="middle" >100 COPD patients and 3594 general population</td><td align="center" valign="middle" >A comparative survey design</td><td align="center" valign="middle" >Between August 2005 and August 2007.</td><td align="center" valign="middle" >SF-36</td><td align="center" valign="middle" >COPD stage and severity</td><td align="center" valign="middle" >Age, Sex, Education level</td></tr><tr><td align="center" valign="middle" >(Obaseki, Erhabor, Awopeju, Obaseki, &amp; Adewole, 2013)</td><td align="center" valign="middle" >50 patients</td><td align="center" valign="middle" >a cross-sectional study</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >Breathlessness, Weight loss, Smoking pack /year</td><td align="center" valign="middle" >Age, Sex, Smoking status, GOLD stage, FEV1/FVC %, BMI</td></tr><tr><td align="center" valign="middle" >(Burgel et al., 2013)</td><td align="center" valign="middle" >326 patients</td><td align="center" valign="middle" >Cross-sectional analysis</td><td align="center" valign="middle" >Between January 2005 and August 2009.</td><td align="center" valign="middle" >HADS SGRQ</td><td align="center" valign="middle" >FEV1%, Exacerbation/patient/year, Dyspnea, Low BMI, CAD/Comorbidity</td><td align="center" valign="middle" >Age, Smoking pack/year, Comorbidities, Current smokers, Sex</td></tr><tr><td align="center" valign="middle" >(Zamzam, Azab, El Wahsh, Ragab, &amp; Allam, 2012)</td><td align="center" valign="middle" >40 patients</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >GOLD stage, FEV1% predicted</td><td align="center" valign="middle" >Smoking index</td></tr><tr><td align="center" valign="middle" >(Joseph, Pascale, Georges, &amp; Mirna, 2012)</td><td align="center" valign="middle" >284 COPD patients from 2201 total sample</td><td align="center" valign="middle" >Cross-sectional study</td><td align="center" valign="middle" >Between October 2009 and September 2010</td><td align="center" valign="middle" >CCQ</td><td align="center" valign="middle" >Cumulative cigarette dose, Older age, having at least one smoker in the family, Lower education, Female gender, Any heart disease, Heating house by diesel, Cumulative waterpipe dose</td><td align="center" valign="middle" >COPD severity scoring</td></tr><tr><td align="center" valign="middle" >(Han et al., 2011)</td><td align="center" valign="middle" >224 African American and 1049 Caucasian subjects with COPD</td><td align="center" valign="middle" >Descriptive design</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >Pack-year smoking history, Younger age, Lower FEV 1% predicted, mMRC, The number of exacerbations</td><td align="center" valign="middle" >Race</td></tr><tr><td align="center" valign="middle" >(Sundh, St&#228;llberg, Lisspers, Montgomery, &amp; Janson, 2011)</td><td align="center" valign="middle" >1548 patients</td><td align="center" valign="middle" >Survey design/different setting</td><td align="center" valign="middle" >In 2005</td><td align="center" valign="middle" >CCQ</td><td align="center" valign="middle" >Educational level, BMI, Heart disease, GOLD stage</td><td align="center" valign="middle" >Sex, Age, Smoking status, comorbidities</td></tr></tbody></table></table-wrap></table-wrap-group><p>Abbreviations: HRQoL, Health-Related Quality of Life; QoL, Quality of Life; SGRQ, St George’s Respiratory Questionnaire; FEV1%, Forced Expiratory Volume in One Second; m MRC, Modified Medical Council Research Dyspnea scale; 6MWD, 6-minute walk distance; CAT, COPD Assessment Test; EQ5D, Euro Qol; CCQ, Clinical COPD Questionnaire; MOS SF-36, Medical Outcome Study of Short Form 36; QWB-SA, Self-Administered Quality of Well-Being Scale; MILQ, Multidimensional Index of Life Quality;</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Study characteristics of correlates and predictors between HRQoL and other variables (N = 22)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Author/ Date</th><th align="center" valign="middle" >Study Sample</th><th align="center" valign="middle" >Study design/ sampling</th><th align="center" valign="middle" >Study Purpose</th><th align="center" valign="middle" >Data Collection period</th><th align="center" valign="middle" >The instrument used to measure HRQoL</th><th align="center" valign="middle" >Main study results</th></tr></thead><tr><td align="center" valign="middle" >(Ivziku, Clari, Piredda, De Marinis, &amp; Matarese, 2019)</td><td align="center" valign="middle" >80 dyads</td><td align="center" valign="middle" >A cross- sectional descriptive design</td><td align="center" valign="middle" >To assess the influence of anxiety and depression on the physical and mental QoL in a patient with COPD and caregiver dyads</td><td align="center" valign="middle" >11 months from November 2016 to October 2017</td><td align="center" valign="middle" >GAD-7 Health Survey (SF-12)</td><td align="center" valign="middle" >This study found that psychological distress affects the QoL of COPD patients and caregivers consistently with prior research that used individual level of analysis and these results confirm the negative impact of anxiety and depression on the caregivers’ mental QoL.</td></tr><tr><td align="center" valign="middle" >(Jarab, Alefishat, Mukattash, Alzoubi, &amp; Pinto, 2018)</td><td align="center" valign="middle" >28 patients</td><td align="center" valign="middle" >Qualitative focused group</td><td align="center" valign="middle" >To explore patients’ views and perceptions regarding COPD and its impact on their quality of life</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >A qualitative study by the focused group and four themes emerged</td><td align="center" valign="middle" >In this qualitative study about patients’ perspectives regarding COPD and its impacts on HRQoL, the evidence was COPD had a negative physical and psychological impact like anxiety on COPD patients.</td></tr><tr><td align="center" valign="middle" >(Brien et al., 2018)</td><td align="center" valign="middle" >735 patients</td><td align="center" valign="middle" >a cross-sectional analysis of cohort study</td><td align="center" valign="middle" >To investigate factors associated with poor QoL, focusing on psychological measures potentially amenable to intervention</td><td align="center" valign="middle" >during the period of May 2012-June 2014</td><td align="center" valign="middle" >EQ-5D CAT GAD-7 scores</td><td align="center" valign="middle" >The study was evident that psychological factors like anxiety significantly contribute to disease-specific QoL impairment in COPD</td></tr><tr><td align="center" valign="middle" >(Quaderi &amp; Hurst, 2018)</td><td align="center" valign="middle" >18 patients and 18 doctors</td><td align="center" valign="middle" >A qualitative method focused group/ convenience sampling</td><td align="center" valign="middle" >To explore the unmet needs of patients from both patients and doctors managing COPD</td><td align="center" valign="middle" >In 2012</td><td align="center" valign="middle" >A qualitative study by the focused group and four themes emerged</td><td align="center" valign="middle" >This study aimed to explore the psychological impacts as an unmet need of patients that could potentially improve their quality of life from both patients’ and doctors’ perspectives whose managing patients with COPD. The study results showed most patients with COPD experienced difficulties in their psychosocial and physical functions such as breathlessness, fear, and helplessness that affect QoL and lead to social isolation.</td></tr><tr><td align="center" valign="middle" >(Kouijzer, Brusse-Keizer, &amp; Bode, 2018)</td><td align="center" valign="middle" >20 form inpatient and outpatient</td><td align="center" valign="middle" >Qualitative semi- structured interview/ purposive sampling</td><td align="center" valign="middle" >To explore the patient’s perspective on the impact of fatigue on their daily lives and on treatment opportunities to tackle the burden of fatigue</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >A qualitative study by the focused group and four themes emerged</td><td align="center" valign="middle" >The study findings indicate that patients with COPD perceive the impact of fatigue on their daily lives to be a key factor in decreasing their quality of life</td></tr><tr><td align="center" valign="middle" >(Stridsman et al., 2018)</td><td align="center" valign="middle" >795 patients</td><td align="center" valign="middle" >Population- based study</td><td align="center" valign="middle" >To evaluate the association between fatigue and health-related quality of life HRQoL both among subjects with and without COPD</td><td align="center" valign="middle" >In 2014</td><td align="center" valign="middle" >FACIT-Fatigue EQ-5D CAT</td><td align="center" valign="middle" >In this population-based study, clinically relevant fatigue was associated with worse HRQoL among subjects with and without COPD when using the clinically useful generic instrument EQ-5D-VAS. Also, among subjects with COPD, clinically relevant fatigue was independently associated with anxiety</td></tr><tr><td align="center" valign="middle" >(Chen et al., 2018)</td><td align="center" valign="middle" >91 patients</td><td align="center" valign="middle" >a cross- sectional study/a survey method</td><td align="center" valign="middle" >To assess the impact of fatigue and dyspnea symptoms on quality of life in individuals with COPD</td><td align="center" valign="middle" >January 2014 to May 2015</td><td align="center" valign="middle" >DI BFI CCQ</td><td align="center" valign="middle" >The symptoms of fatigue, Dyspnea, and anxiety were moderate to highly correlate with each other, and with HRQoL. Thus, all individuals have an impact on their health-related quality of life.</td></tr><tr><td align="center" valign="middle" >(Lim, Kim, Kim, &amp; Kim, 2017)</td><td align="center" valign="middle" >130 patients</td><td align="center" valign="middle" >A descriptive cross- sectional design/ convenient sampling</td><td align="center" valign="middle" >To identify symptom clusters and the effects on quality of life (QOL) in patients with COPD</td><td align="center" valign="middle" >Between November and December 2014</td><td align="center" valign="middle" >Korean version of the CAT</td><td align="center" valign="middle" >Symptom cluster 1 consisted of dyspnea, physical functional status, and dry mouth; symptom cluster 2 consisted of anxiety and depression, and symptom cluster 3 consisted of sleep disturbance and fatigue. Subgroup cluster analysis showed that COPD subjects with higher-scoring symptoms in symptom clusters 1, 2, and 3 had significantly poorer QOL.</td></tr><tr><td align="center" valign="middle" >(Pascal, Trofor, Lotrean, Filipeanu, &amp; Trofor, 2017)</td><td align="center" valign="middle" >60 patients</td><td align="center" valign="middle" >an observational study</td><td align="center" valign="middle" >To assess anxiety, depression and panic disorders among patients diagnosed with COPD and to investigate their correlation with disease severity, QoL as well as tobacco use</td><td align="center" valign="middle" >Between January and September 2014</td><td align="center" valign="middle" >HADS CAT</td><td align="center" valign="middle" >The results indicated associations between anxiety, depression, panic attacks, and disease severity, as well as poor quality of life of patients with COPD, regardless of their current tobacco use status.</td></tr><tr><td align="center" valign="middle" >(Mewes, Rief, Kenn, Ried, &amp; Stenzel, 2016)</td><td align="center" valign="middle" >502 patients</td><td align="center" valign="middle" >a cross-sectional online survey</td><td align="center" valign="middle" >To investigate the influence of psychological factors on HRQL and disability in COPD individuals recruited from the general population.</td><td align="center" valign="middle" >Between May and September 2012</td><td align="center" valign="middle" >Health Survey (SF-12) PHQ</td><td align="center" valign="middle" >High depression and anxiety were the main predictors of low mental HRQoL. an association was found between strong emotional reactions to COPD and low mental HRQoL</td></tr><tr><td align="center" valign="middle" >(Martinez et al., 2016)</td><td align="center" valign="middle" >4097 patients</td><td align="center" valign="middle" >a cross-sectional analysis of data from participants with COPD in two cohorts</td><td align="center" valign="middle" >To explore factors associated with age-related differences in HRQL in COPD.</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >SGRQ</td><td align="center" valign="middle" >Anxiety was associated with change and predicting HRQoL</td></tr><tr><td align="center" valign="middle" >(Paap, Bode, Lenferink, Terwee, &amp; van der Palen, 2015)</td><td align="center" valign="middle" >13 Health care professionals</td><td align="center" valign="middle" >Qualitative study/face to face interview</td><td align="center" valign="middle" >To identify which domains of HRQoL are most important for patients with COPD from the perspective of healthcare professionals</td><td align="center" valign="middle" >From July through December 2013</td><td align="center" valign="middle" >Seven main themes emerged from the analysis of the open question</td><td align="center" valign="middle" >The study findings report the most frequently selected Patient-Reported Outcomes Measures (PROMs) domains which are fatigue, physical function, emotional support, anxiety, and depression that showed the most important domains to measure and associated with HRQoL among patients with COPD.</td></tr><tr><td align="center" valign="middle" >(Mehta et al., 2014)</td><td align="center" valign="middle" >59 patients</td><td align="center" valign="middle" >a cross-sectional study</td><td align="center" valign="middle" >To study the association of psychiatric co-morbidities and QoL with the severity of COPD.</td><td align="center" valign="middle" >Between September and November 2013</td><td align="center" valign="middle" >HADS SGRQ</td><td align="center" valign="middle" >Patients with depression and anxiety disorders were likely to have a poorer quality of life represented by higher SGRQ scores. Also, patients with severe respiratory symptoms are more likely to suffer from anxiety disorders and depression and have a poorer quality of life.</td></tr><tr><td align="center" valign="middle" >(Miyazaki et al., 2014)</td><td align="center" valign="middle" >336 COPD patients and 67 non-COPD subjects</td><td align="center" valign="middle" >an observational study</td><td align="center" valign="middle" >To investigate comorbid factors that may contribute to high CAT scores</td><td align="center" valign="middle" >Between April 2010 and December 2012</td><td align="center" valign="middle" >SF-36 version 2 CAT SGRQ HADS</td><td align="center" valign="middle" >There is a significant-good correlation with the SGRQ total score, all components of the SF-36, and CAT score with anxiety in the COPD patients.</td></tr><tr><td align="center" valign="middle" >(Al-Gamal, 2014)</td><td align="center" valign="middle" >67 patients and spouses</td><td align="center" valign="middle" >a cross- sectional, descriptive, correlational design/ interview</td><td align="center" valign="middle" >To examine the relationships between anxiety, depression, and QoL of both Jordanian patients with COPD and their spouses</td><td align="center" valign="middle" >in 2011</td><td align="center" valign="middle" >QLI HADS</td><td align="center" valign="middle" >There was a significant negative correlation between total patient QoL scores and depression subscale score and anxiety sub-scale This indicated that patients with high psychological distress reported poor QoL.</td></tr><tr><td align="center" valign="middle" >(Burgel et al., 2013)</td><td align="center" valign="middle" >326 patients</td><td align="center" valign="middle" >a cross-sectional analysis</td><td align="center" valign="middle" >To evaluate the independent contribution of comorbidities including mood disorders, metabolic and cardiovascular comorbidities to SGRQ scores</td><td align="center" valign="middle" >Between January 2005 and August 2009.</td><td align="center" valign="middle" >HADS SGRQ</td><td align="center" valign="middle" >The univariate data in this study indicated that COPD subjects with anxiety or depression had worse HRQoL</td></tr><tr><td align="center" valign="middle" >(Hoth et al., 2013)</td><td align="center" valign="middle" >407 patients</td><td align="center" valign="middle" >Survey study/online survey</td><td align="center" valign="middle" >The primary objective was to determine whether ambiguity or complexity has a stronger impact on depressive symptoms, anxiety, quality of life, and breathlessness.</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >MUIS HADS SGRQ</td><td align="center" valign="middle" >Uncertainty about physical symptoms which is ambiguity consistently predicted depression, anxiety, quality of life, and breathlessness over a two-year period among individuals with COPD while uncertainty about treatment and the healthcare system which is complexity did not have an independent effect on any of the previous outcome variables.</td></tr><tr><td align="center" valign="middle" >(Lou et al., 2012)</td><td align="center" valign="middle" >1100 patients</td><td align="center" valign="middle" >A case-controlled study/A cluster- randomized sampling</td><td align="center" valign="middle" >To assess depression and anxiety in Chinese patients with COPD</td><td align="center" valign="middle" >Between March and May 2008</td><td align="center" valign="middle" >SGRQ HADS</td><td align="center" valign="middle" >Patients with COPD who had anxiety and/or depression had a poorer health-related quality of life</td></tr><tr><td align="center" valign="middle" >(Jiang &amp; He, 2012)</td><td align="center" valign="middle" >96 patients</td><td align="center" valign="middle" >RCT</td><td align="center" valign="middle" >To explore the effects of an uncertainty management intervention on uncertainty, anxiety, depression, and QoL of COPD outpatients in China</td><td align="center" valign="middle" >10-month study duration</td><td align="center" valign="middle" >MUIS-A SGRQ STAI</td><td align="center" valign="middle" >This study suggests that an uncertainty management intervention is effective in improving uncertainty, anxiety, depression, and quality of life in COPD outpatients. It is provided the first evidence that uncertainty management can improve the QoL of COPD patients</td></tr><tr><td align="center" valign="middle" >(Baltzan et al., 2011)</td><td align="center" valign="middle" >251 individuals</td><td align="center" valign="middle" >observational study/a secondary analysis of data collected during a randomized clinical trial</td><td align="center" valign="middle" >To determine whether patients with high fatigue differed in their response to pulmonary rehabilitation program compared to those with low reported fatigue both immediately after the program and 1 year after entry.</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SGRQ CRQ 6MWD</td><td align="center" valign="middle" >In this study patients in both groups are improved similarly in their dyspnea, the 6MWD and endurance time after introducing a pulmonary rehabilitation program. However, high-fatigue patients had greater improvements in both the CRQ fatigue and the SGRQ scores. thus, this study suggests that high levels of fatigue are a common feature in patients with COPD</td></tr><tr><td align="center" valign="middle" >(Balcells et al., 2010)</td><td align="center" valign="middle" >337 patients</td><td align="center" valign="middle" >a cross-sectional analysis/ convenient sampling</td><td align="center" valign="middle" >To evaluate the association between anxiety and depressive symptoms and health-related quality of life (HRQoL), and to identify the effect modifiers of this relationship in patients with chronic obstructive pulmonary disease</td><td align="center" valign="middle" >between January 2004 and March 2006.</td><td align="center" valign="middle" >SGRQ HADS</td><td align="center" valign="middle" >This study showed a significant association between anxiety, depression or both and reduced HRQOL.</td></tr><tr><td align="center" valign="middle" >(Borge, Wahl, &amp; Moum, 2010)</td><td align="center" valign="middle" >154 patients</td><td align="center" valign="middle" >a cross-sectional study</td><td align="center" valign="middle" >To explore the relationships between demographic and clinical variables and the symptoms of breathlessness, depression, anxiety, fatigue, sleeping difficulties and pain for patients with COPD.</td><td align="center" valign="middle" >from June 2006 to December 2007</td><td align="center" valign="middle" >HADS Lee Fatigue Scale (LFS) RQLQ</td><td align="center" valign="middle" >This study confirms breathlessness is associated with variables of anxiety and fatigue which affect the QoL in patients with COPD.</td></tr></tbody></table></table-wrap><p>Abbreviation: CAT, COPD assessment test; HADS, Hospital Anxiety and Depression Scale; SGRQ, St George’s Respiratory Questionnaire; PHQ, Patient Health Questionnaire; RCT, Randomized Clinical Trial; MUIS-A, Mishel’s Uncertainty in Illness Scale-‎Adult version; STAI, State-Trait Anxiety Inventory; QLI, Quality of Life Index; FACIT-‎Fatigue, Functional Assessment of Chronic Illness-Fatigue; GAD-7, Generalized Anxiety Disorder 7-item scale; RQLQ, Respiratory Quality of Life Questionnaire; BFI, Brief Fatigue Inventory; DI, Dyspnea Inventory‎; CCQ, Clinical COPD questionnaire; CRQ, Chronic Respiratory Questionnaire.</p><sec id="s3_1"><title>3.1. Predictors Related to Sociodemographic and Clinical Variables</title><p>The correlation between HRQoL and age was discussed in several studies, and the results were controversial. Almost seven studies were reported a positive correlation between age and HRQoL [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] - [<xref ref-type="bibr" rid="scirp.96920-ref28">28</xref>]. The SGRQ-c tool was used to measure the HRQoL primarily and the EQ-5D tool was the second. In addition, a few tools were developed by the study researchers. On the other hand, in SGRQ-c the impact of the score was high indicating more worsening of social function and psychosocial disturbances with aging, this could be clarified by the fact that aging is usually linked with impaired activity, depressive symptoms, and anxiety [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref31">31</xref>]. On the contrary, nearly twelve studies were found a nonsignificant correlation between age and HRQoL indicating age didn’t cause impaired HRQoL among those patients [<xref ref-type="bibr" rid="scirp.96920-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref32">32</xref>] - [<xref ref-type="bibr" rid="scirp.96920-ref42">42</xref>].</p><p>The gender was correlated with HRQoL. A huge variation was between studies in predicting the gender correlation with HRQoL. Although many studies were found a correlation between two variables as shown in <xref ref-type="table" rid="table1">Table 1</xref>. The female patients had lower scores of HRQoL compared with male patients in the following studies [<xref ref-type="bibr" rid="scirp.96920-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref27">27</xref>]. The following five studies showed no significant correlation or difference between the two variables [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref43">43</xref>].</p><p>The educational level was correlated with impaired HRQoL indicating lower educational levels causing worse HRQoL in four studies [<xref ref-type="bibr" rid="scirp.96920-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref33">33</xref>]. In contrast, five studies were showed no correlation between educational level and better HRQoL according to the type of HRQoL measures that have been utilized in these studies [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref37">37</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref38">38</xref>].</p><p>The comorbidities’ status and type of disease as clinical variables were correlated with HRQoL. Moreover, the majority of studies should report more than two diseases to confirm the existence of comorbidities associated with HRQoL. The six studies have reported a correlation indicating the presence of two or more of the following diseases, ischemic heart disease or diabetes, or hypertension [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref43">43</xref>]. While only two studies confirm the correlation between HRQoL with comorbidities status and types [<xref ref-type="bibr" rid="scirp.96920-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref33">33</xref>]. However, many studies have reported the existence of comorbidities without explaining the type of comorbidities as it is shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>The severity of disease was considered the main factor to evaluate the disease progression and effectiveness of treatment. Sometimes it was linked with medication status and type of medication given to the patients through the course of treatment. The severity indicator factors are FEV1% predicted, GOLD staging, ABCD Criteria, CAT score, mMRC score, and FEV1/FVC%. Six studies were reported more than two factors as a predictor regarding the severity of disease [<xref ref-type="bibr" rid="scirp.96920-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref44">44</xref>] while only three studies were reported not more than two factors that non predicting the HRQoL [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref45">45</xref>]. However, most factors were reported, FEV1% predicted, FEV1/FVC%, CAT score, and GOLD stages.</p><p>Furthermore, the duration of disease, a number of hospitalizations, smoking behaviors and packs/year, and effect of weight measured by BMI were other clinical variables which discussed the correlation with HRQoL. Although many studies had confirmed these factors as a predictor, other studies reporting inconsistency with the same variables as not predicting factors as shown in <xref ref-type="table" rid="table1">Table 1</xref>. Moreover, there were widespread debates about the amount of smoke and behavior and it is a correlation with HRQoL. Six studies were reported no correlation between smoking behavior and the smoking indexes with HRQoL [<xref ref-type="bibr" rid="scirp.96920-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref43">43</xref>], while in the following eight studies [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref46">46</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref47">47</xref>] were reported an existence of correlation between smoking behaviors, smoking index, and HRQoL.</p><p>On the other hand, an old study carried out by Wijnhoven and his colleagues [<xref ref-type="bibr" rid="scirp.96920-ref48">48</xref>] reported a controversial result indicating better HRQoL in current smokers. The reasons that patients who are still smoking might be those with a less advanced stage of the disease. While another new study showed current smokers have a poorer quality of life (high total HRQoL score) compared with previous smokers [<xref ref-type="bibr" rid="scirp.96920-ref26">26</xref>].</p><p>Recently, new studied variables were discussed as a factors which correlates and predicting HRQoL, such as; type of work which was reported in one study [<xref ref-type="bibr" rid="scirp.96920-ref36">36</xref>], socioeconomic status in two studies [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref24">24</xref>], nutrition type in one study [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>], and the presence of family help and support in one study [<xref ref-type="bibr" rid="scirp.96920-ref24">24</xref>]. In contrast, the following studies were found type of works [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref37">37</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref40">40</xref>], socioeconomic status [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref40">40</xref>], and living status [<xref ref-type="bibr" rid="scirp.96920-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref38">38</xref>] not predicting the HRQoL in their population sample. Moreover, one study has reported the factors of areas of residency and seasonal variation effect. These factors were found not predicting the HRQoL [<xref ref-type="bibr" rid="scirp.96920-ref32">32</xref>]. Only one study has reported the correlation with pain, this factor was found not predicting the HRQoL [<xref ref-type="bibr" rid="scirp.96920-ref31">31</xref>].</p><p>A few studies have discussed the effectiveness of an interventional program. The 6MWD test is widely used among COPD patients. This test was correlated with lower scores of HRQoL in recent tow studies (best HRQoL) [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref43">43</xref>]. Regarding the medication use was verified as a predictor of HRQoL. Shah and colleagues [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>], Sharma and Joshi [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>], Raherison and colleagues [<xref ref-type="bibr" rid="scirp.96920-ref34">34</xref>] demonstrated that deterioration in HRQoL was seen correlating with the number of prescribed medications, whereas other studies [<xref ref-type="bibr" rid="scirp.96920-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref47">47</xref>] were showed that the patients with the greatest impairment of HRQoL are those who are taking more than one medication, and those contained especially inhaled corticosteroids.</p><p>Together, numerous studies identified that lower education levels, more breathlessness, fatigue, lower BMI, anxiety, and depressive symptoms adversely affect the HRQoL. [<xref ref-type="bibr" rid="scirp.96920-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref49">49</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref50">50</xref>]. In conclusion, the most common predictors of HRQoL among COPD patients were age, GOLD severity stage of the disease, dyspnea grade, and the number of exacerbations/hospitalizations. Other predicting factors include comorbidity, sex, body mass index, socioeconomic status, and educational level.</p><p>The Health-related quality of life was measured by using different generic and specific tools including general short-form (SF-12) health survey questionnaire which was utilized in three studies [<xref ref-type="bibr" rid="scirp.96920-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref51">51</xref>], MOS SF 36 was utilized in one study [<xref ref-type="bibr" rid="scirp.96920-ref33">33</xref>], and the specific one such as SGRQ-c was utilized in nine studies [<xref ref-type="bibr" rid="scirp.96920-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref37">37</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref43">43</xref>], EQ-5D was utilized in two studies [<xref ref-type="bibr" rid="scirp.96920-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref13">13</xref>], Clinical COPD Questionnaire (CCQ) was utilized in four studies. [<xref ref-type="bibr" rid="scirp.96920-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref41">41</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref46">46</xref>], and a newly developed one by study researchers was utilized in three studies [<xref ref-type="bibr" rid="scirp.96920-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref38">38</xref>]. The frequently utilized tool was the SGRQ-c through all reported studies. The SGRQ-c is a specific tool to measure the severity and HRQoL among patients with COPD. Out of all reported studies, most of the studies were solely used one tool to measure HRQoL, only two studies were used two types of tools in order to compare the level of HRQoL from two types of measurement and to report if there is a significant difference between each tool [<xref ref-type="bibr" rid="scirp.96920-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref52">52</xref>]. Before it was common to see more than two types of tools were utilized to test HRQoL because of the need to cover all aspects of HRQoL, but now utilizing one specific tool is enough which covered the main aspects of HRQoL.</p><p>On the other hand, the majority of the study was utilized observational design in cross-sectional and longitudinal time series. The sample size was adequate the minimum in some studies was not less than 40 participants and the maximum, not more than 2734 participants. However, a few studies such as web-based surveys or prospective studies were failed to report the data collection period as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s3_2"><title>3.2. Correlates and Predictors between HRQoL and Other Variables</title><sec id="s3_2_1"><title>3.2.1. Perceived Anxiety and Fatigue</title><p>The patients with COPD experience a wide range of burdens which were represented with several symptoms, such as breathlessness, anxiety, and fatigue. These symptoms affect disease assessment and management. Fatigue was reported to be one of the most common symptoms among patients with COPD [<xref ref-type="bibr" rid="scirp.96920-ref53">53</xref>]. The patients with a chronic disease rated fatigue often as one of the key factors leading to reduced QoL [<xref ref-type="bibr" rid="scirp.96920-ref12">12</xref>]. However, the prevalence rate of fatigue was shown that almost half of all patients experienced abnormal fatigue: 23% mild and 24% severe fatigue in a study concerning the severity of fatigue in patients with stable, moderate to severe COPD [<xref ref-type="bibr" rid="scirp.96920-ref54">54</xref>]. While the prevalence rates for anxiety range from 17% to 51% [<xref ref-type="bibr" rid="scirp.96920-ref55">55</xref>]. Further, two studies supported that COPD patients have a higher incidence of anxiety 21% to 96% compared to 20% in the general population [<xref ref-type="bibr" rid="scirp.96920-ref50">50</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref56">56</xref>]. Other studies were found that 90% of patients diagnosed with severe COPD suffered from severe breathing difficulty which was complicated by psychological distress related to anxiety and/or depression. The combination of factors resulted in an increased number of severe symptoms, hospitalization, and hospital mortality [<xref ref-type="bibr" rid="scirp.96920-ref56">56</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref57">57</xref>].</p><p>Almost three studies discussed the correlation of HRQoL with fatigue. The qualitative study conducted by Kouijzer and colleagues [<xref ref-type="bibr" rid="scirp.96920-ref12">12</xref>], the authors pointed out the purpose of the study was to examine the patient’s perspective on COPD-related fatigue, the impact on activity daily life, and possible treatment opportunities to tackle the burden of fatigue. The study results showed the COPD-related fatigue causes a severe, negative impact on the physical, emotional, cognitive and social functioning of all participants. The negative impacts on daily functioning were negatively influenced by the HRQoL of patients leading to a heavy mental burden, decreasing patients’ joy in life, and even in some cases their will to live. A qualitative study with face to face interviews was conducted to identify the domains of HRQoL from the perspectives of health care professionals. The study found fatigue and anxiety were the most important aspect correlated with impairment in HRQoL [<xref ref-type="bibr" rid="scirp.96920-ref10">10</xref>]. The two cross-sectional descriptive studies found a high correlation between disease symptoms like dyspnea, breathlessness with anxiety and fatigue which have an impact on the HRQoL among COPD patients [<xref ref-type="bibr" rid="scirp.96920-ref50">50</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref58">58</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref59">59</xref>].</p><p>Furthermore, a population-based study of (795) participants. The study was conducted to evaluate the correlation and compare between fatigue and HRQoL among COPD and Non-COPD patients. The study found clinically significant fatigue was correlated with worse HRQoL and independently correlated with anxiety [<xref ref-type="bibr" rid="scirp.96920-ref60">60</xref>]. Moreover, an observational study from secondary collected data was embedded within a randomized trial to test the effectiveness of pulmonary rehabilitation program on the level of activity and fatigue. The study results found that high fatigue patients had a greater improvement in both fatigue score in a chronic respiratory questionnaire and the SGRQ scores which indicate a high level of fatigue cause deterioration in the level of HRQoL with COPD patients [<xref ref-type="bibr" rid="scirp.96920-ref61">61</xref>].</p><p>Further studies about the correlation of HRQoL with anxiety, about five cross-sectional studies with an adequate sample size were conducted to evaluate the correlation between HRQoL and anxiety as shown in <xref ref-type="table" rid="table2">Table 2</xref>. Numerous studies had confirmed the results of COPD patients with anxiety had a poorer HRQoL and anxiety was the predictor of low mental HRQoL score [<xref ref-type="bibr" rid="scirp.96920-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref62">62</xref>] - [<xref ref-type="bibr" rid="scirp.96920-ref67">67</xref>]. Two qualitative studies with a focused group method were conducted. The studies aimed to explore patients’ views and perceptions regarding COPD and their impacts on daily living. The results emerged four themes indicating that most patients with COPD experiencing difficulties in their psychosocial like anxiety and physical functions that affect their HRQoL and ultimately lead to social isolation [<xref ref-type="bibr" rid="scirp.96920-ref18">18</xref>].</p><p>On the other hand, fatigue was measured by using different tools including HADS were utilized in seven studies [<xref ref-type="bibr" rid="scirp.96920-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref64">64</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref67">67</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref68">68</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref69">69</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref70">70</xref>], STAI was utilized in one study [<xref ref-type="bibr" rid="scirp.96920-ref71">71</xref>], FACIT was utilized in one study [<xref ref-type="bibr" rid="scirp.96920-ref59">59</xref>], GAD-7 was used in two studies [<xref ref-type="bibr" rid="scirp.96920-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref72">72</xref>], LFS was used in one study [<xref ref-type="bibr" rid="scirp.96920-ref50">50</xref>], BFI was used in one study [<xref ref-type="bibr" rid="scirp.96920-ref58">58</xref>]. The most frequently used tool was the HADS among all reported studies. This tool is a generic tool used to test anxiety and depression. Regarding fatigue, the GAD-7 was utilized as the most specific tool that has been used among COPD patients.</p></sec><sec id="s3_2_2"><title>3.2.2. Uncertainty among COPD</title><p>Uncertainty is defined as ‘‘inability to determine the meaning of illness-related events’’ [<xref ref-type="bibr" rid="scirp.96920-ref73">73</xref>]. However, if the expectations of health care providers differ from the expectations of patients, further confusion and patient uncertainty may be added [<xref ref-type="bibr" rid="scirp.96920-ref74">74</xref>]. Uncertainty about prognosis and symptoms is fundamental in living with a chronic health condition. COPD is characterized by breathlessness and airflow limitation that is not fully reversible. Thus, treatment focuses on managing symptoms and maintaining the HRQoL. The patients must recognize and appropriately understand their symptoms to take inhaler medications and seek evaluation for appropriate management [<xref ref-type="bibr" rid="scirp.96920-ref68">68</xref>]. There was a scarcity in the studies test a correlation of HRQoL with uncertainty. The old two studies were examined uncertainty among COPD patients based on a sample of (26) hospitalized patients [<xref ref-type="bibr" rid="scirp.96920-ref75">75</xref>] [<xref ref-type="bibr" rid="scirp.96920-ref76">76</xref>]. One more study has tested the effectiveness of a specific intervention to manage uncertainty [<xref ref-type="bibr" rid="scirp.96920-ref71">71</xref>]. In this study, the authors found a reduction in uncertainty and improvement in anxiety, depression, and quality of life among the intervention group.</p><p>A relatively recent longitudinal study over two years was used to determine which aspect of illness uncertainty (i.e., ambiguity or complexity) has a significant correlation with psychological and selected clinical outcomes over a two year period among patients with COPD. The study results showed the greater uncertainty is correlated with more symptoms of depression and anxiety and reduced QoL. In addition, it was also correlated with worse physical symptoms (i.e., pain and fatigue) [<xref ref-type="bibr" rid="scirp.96920-ref68">68</xref>]. Further studies are needed to investigate more about the uncertainty concept, and it is a correlation with HRQoL.</p></sec></sec></sec><sec id="s4"><title>4. Discussion</title><p>The aim of this integrative review was to update, identify, and summarize kinds of literature that described HRQoL predictors and correlation of HRQoL with other variables limited to anxiety, fatigue, and uncertainty in patients with COPD. After a comprehensive search, the authors believe this is the first review conducted to cover the HRQoL correlations with variables of fatigue, anxiety, and uncertainty in specific and identifying between predicting and non predicting factors with HRQoL from (52) studies were included in this review. However, the previous review has described only the factors predicting the HRQoL, it was limited in the scope of articles, keywords of search engines, and searching coverage periods [<xref ref-type="bibr" rid="scirp.96920-ref77">77</xref>]. In the current study, <xref ref-type="table" rid="table1">Table 1</xref> “characteristics of the studies analyzing factors predicting the HRQL of patients with COPD” was included to evaluate the predictors of HRQoL across different studies. ‎<xref ref-type="table" rid="table2">Table 2</xref> “study characteristics of correlates and predictors between HRQoL and other variables‎” was included to evaluate the correlation with HRQoL and other important variables. The tables were classified according to sample size, study design, data collection period, sampling methods, and type of tool used to measure HRQoL. The two tables have presented a disagreement in the literature about the factors that predicting and non predicting the HRQoL among COPD patients.</p><p>The predictor factors were categorized according to factors related to demographic and clinical variables. What is new in this review, some related factors were examined which not discussed before in the literature. The factors were found as predictors of HRQoL such as; patient living status, work status and type, and help and support provider. Although numerous studies have been devoted to studying predictors of HRQoL and correlated factors in recent years among COPD patients, some HRQoL aspects remain unclear and need more investigations. A group of physical, emotional, and psychosocial factors was identified that correlated and altered of HRQoL. In conclusion, there is a discrepancy in the factors predicting and correlated HRQoL among COPD patients within the literature when utilizing specific tools to measure HRQoL.</p><p>Furthermore, this review identifies the instruments that had been used for collecting data indicating the SGRQ-c was the most utilized tool in the mentioned studies to measure HRQoL, the HADS to measure the anxiety, and the GAD-7 to measure fatigue, and the MUIS to measure uncertainty. Further, about the correlation with HRQoL, there was a significant correlation between anxiety, fatigue, and HRQoL among COPD patients. The literature still lacks clarity about the correlation of HRQoL with uncertainty among COPD patients. Further researches are needed to verify the validity of the reported correlation between HRQoL and other variables. In addition to a correlation with other sociodemographic and clinical variables to confirm the significant predictors.</p><p>‎Moreover, most of the reported studies have been carried out in developed countries. A few types of research have been carried out in developing countries. Cultural variations, pollution-related exposure, and special behaviors must be considered when disseminating the findings obtained from these studies. Contradicting findings are apparent in certain predictors of HRQoL as shown earlier in the provided tables. Additionally, the correlation with HRQoL was categorized according to correlation with perceived anxiety and fatigue and correlation with uncertainty. On the other hand, the studies included in this review were different in reporting quantitative and qualitative research design, sample size, and data collection methods and time period.</p></sec><sec id="s5"><title>5. Limitations</title><p>Despite the important integrated findings in this review, the authors suggest that there are some limitations to be acknowledged. Excluding non-English language articles can minimize the chance of accessing some relevant literature. Additionally, most samples included participants from diverse cultural groups, complicating the generalizability of these studies, and making generalizations with respect to each study difficult. Finally, the heterogeneity among the studies in terms of the methodologies used and assessment tools makes it difficult to accurately compare various aspects of the outcomes reported.</p></sec><sec id="s6"><title>6. Conclusion</title><p>Health-related quality of life was low among patients with COPD. The HRQoL was decreased with the presence of anxiety and fatigue with COPD. There are many predictors that affect HRQoL with COPD. These predictors need more investigation and evaluation. The evaluation of HRQoL predictors among COPD patients should need to consider the measurement tools of HRQoL. The assessment of physical and psychological factors is important for improving COPD symptoms, preventing the consequent deterioration of HRQoL, and choosing the appropriate treatments. The literature demonstrated that HRQoL among COPD patients is apparent as an issue that needs further investigation from cultural perspectives. Certain predictors still have contradictory findings in the non-empirical literature. This review will expect to help in resolving discrepancies in the existing literature about predictors and correlated factors among COPD patients. It would be valuable to rule out which of these factors remain valid to predict HRQoL in a specific population and cultures. In clinical practice, screening for anxiety, fatigue, and uncertainty would refer potentially affected patients to specific care facilities for further assessment that may be promising approaches to improve the HRQoL among those patients. The findings from this review should encourage health care providers to explore carefully the predictors during patient history taking and interviews as an aid to help them understand why some patients may not respond to provided care options and why some of them are at high risk to a certain limit. This review will guide health care professionals to understand their patients in a more holistic manner.</p></sec><sec id="s7"><title>Acknowledgements</title><p>The authors thank the School of Nursing, University of Jordan for their support in conducting this review.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Tabar, N.A. and Alshraideh, J.A. (2019) Correlates and Predictors of Health-Related Quality of Life among Patients with ‎‎COPD: An Integrative Review. Open Journal of Nursing, 9, 1203-1225. https://doi.org/10.4236/ojn.2019.912088</p></sec></body><back><ref-list><title>References</title><ref id="scirp.96920-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">GOLD (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2019 Report.</mixed-citation></ref><ref id="scirp.96920-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Sarioglu, N., Hismiogullari, A., Bilen, C. and Erel, F. (2016) Is the COPD Assessment Test (CAT) Effective in Demonstrating the Systemic Inflammation and Other Components in COPD? Revista Portuguesa de Pneumologia (English Edition), 22, 11-17. https://doi.org/10.1016/j.rppnen.2015.08.007</mixed-citation></ref><ref id="scirp.96920-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2019) COPD: Definition. https://www.who.int/respiratory/copd/definition/en/</mixed-citation></ref><ref id="scirp.96920-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Quaderi, S.A. and Hurst, J.R. (2018) The Unmet Global Burden of COPD. Global Health, Epidemiology and Genomics, 3, e4. https://doi.org/10.1017/gheg.2018.1</mixed-citation></ref><ref id="scirp.96920-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2015) Projections of Mortality and Causes of Death, 2015 and 2030. The World Health Organization, Geneva, Switzerland.</mixed-citation></ref><ref id="scirp.96920-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ding, B., Small, M., Bergstr&amp;#246;m, G. and Holmgren, U. (2017) COPD Symptom Burden: Impact on Health Care Resource Utilization, and Work and Activity Impairment. International Journal of Chronic Obstructive Pulmonary Disease, 12, 677-689. https://doi.org/10.2147/COPD.S123896</mixed-citation></ref><ref id="scirp.96920-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Brien, S.B., Stuart, B., Dickens, A.P., Kendrick, T., Jordan, R.E., Adab, P. and Thomas, M. (2018) Independent Determinants of Disease-Related Quality of Life in COPD—Scope for Nonpharmacologic Interventions? International Journal of Chronic Obstructive Pulmonary Disease, 13, 247-256. https://doi.org/10.2147/COPD.S152955</mixed-citation></ref><ref id="scirp.96920-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ekici, A., Bulcun, E., Karakoc, T., Senturk, E. and Ekici, M. (2015) Factors Associated with Quality of Life in Subjects with Stable COPD. Respiratory Care, 60, 1585-1591. https://doi.org/10.4187/respcare.03904</mixed-citation></ref><ref id="scirp.96920-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Karimi, M. and Brazier, J. (2016) Health, Health-Related Quality of Life, and Quality of Life: What Is the Difference? PharmacoEconomics, 34, 645-649. https://doi.org/10.1007/s40273-016-0389-9</mixed-citation></ref><ref id="scirp.96920-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Paap, M.C.S., Bode, C., Lenferink, L.I.M., Terwee, C.B. and van der Palen, J. (2015) Identifying Key Domains of Health-Related Quality of Life for Patients with Chronic Obstructive Pulmonary Disease: Interviews with Healthcare Professionals. Quality of Life Research, 24, 1351-1367. https://doi.org/10.1007/s11136-014-0860-z</mixed-citation></ref><ref id="scirp.96920-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kwon, H.-Y. and Kim, E. (2016) Factors Contributing to Quality of Life in COPD Patients in South Korea. International Journal of Chronic Obstructive Pulmonary Disease, 11, 103-109. https://doi.org/10.2147/COPD.S90566</mixed-citation></ref><ref id="scirp.96920-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kouijzer, M., Brusse-Keizer, M. and Bode, C. (2018) COPD-Related Fatigue: Impact on Daily Life and Treatment Opportunities from the Patient’s Perspective. Respiratory Medicine, 141, 47-51. https://doi.org/10.1016/j.rmed.2018.06.011</mixed-citation></ref><ref id="scirp.96920-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Hong, J.Y., Kim, S.Y., Chung, K.S., Kim, E.Y., Jung, J.Y., Park, M.S. and Kim, Y.S. (2015) Factors Associated with the Quality of Life of Korean COPD Patients as Measured by the EQ-5D. Quality of Life Research, 24, 2549-2558. https://doi.org/10.1007/s11136-015-0979-6</mixed-citation></ref><ref id="scirp.96920-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Agusti, A., Bel, E., Thomas, M., Vogelmeier, C., Brusselle, G., Holgate, S. and Vestbo, J. (2016) Treatable Traits: Toward Precision Medicine of Chronic Airway Diseases. European Respiratory Journal, 47, 410-419. https://doi.org/10.1183/13993003.01359-2015</mixed-citation></ref><ref id="scirp.96920-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Zamzam, M.A., Azab, N.Y., El Wahsh, R.A., Ragab, A.Z. and Allam, E.M. (2012) Quality of Life in COPD Patients. Egyptian Journal of Chest Diseases and Tuberculosis, 61, 281-289. https://doi.org/10.1016/j.ejcdt.2012.08.012</mixed-citation></ref><ref id="scirp.96920-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Brandl, M., B&amp;#246;hmer, M.M., Brandstetter, S., Finger, T., Fischer, W., Pfeifer, M. and Apfelbacher, C. (2018) Factors Associated with Generic Health-Related Quality of Life (HRQOL) in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Cross-Sectional Study. Journal of Thoracic Disease, 10, 766-775. https://doi.org/10.21037/jtd.2018.01.122</mixed-citation></ref><ref id="scirp.96920-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Farag, T.S., Sobh, E.S.M., Elsawy, S.B. and Fahmy, B.M. (2018) Evaluation of Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease. The Egyptian Journal of Bronchology, 12, 288-294. https://doi.org/10.4103/ejb.ejb_11_18</mixed-citation></ref><ref id="scirp.96920-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Jarab, A., Alefishat, E., Mukattash, T., Alzoubi, K. and Pinto, S. (2018) Patients’ Perspective of the Impact of COPD on Quality of Life: A Focus Group Study for Patients with COPD. International Journal of Clinical Pharmacy, 40, 573-579. https://doi.org/10.1007/s11096-018-0614-z</mixed-citation></ref><ref id="scirp.96920-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Burgel, P.-R., Escamilla, R., Perez, T., Carré, P., Caillaud, D., Chanez, P., et al. (2013) Impact of Comorbidities on COPD-Specific Health-Related Quality of Life. Respiratory Medicine, 107, 233-241. https://doi.org/10.1016/j.rmed.2012.10.002</mixed-citation></ref><ref id="scirp.96920-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Yorgancioglu, A., Havlucu, Y., Celik, P., Dinc, G. and Saka, A. (2010) Relation between Quality of Life and Morbidity and Mortality in COPD Patients: Two-Year Follow-Up Study. COPD: Journal of Chronic Obstructive Pulmonary Disease, 7, 248-253. https://doi.org/10.3109/15412555.2010.496816</mixed-citation></ref><ref id="scirp.96920-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Weldam, S.W.M., Schuurmans, M.J., Liu, R. and Lammers, J.-W.J. (2013) Evaluation of Quality of Life Instruments for Use in COPD Care and Research: A Systematic Review. International Journal of Nursing Studies, 50, 688-707. https://doi.org/10.1016/j.ijnurstu.2012.07.017</mixed-citation></ref><ref id="scirp.96920-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Higginson, I.J. and Carr, A.J. (2001) Measuring Quality of Life: Using Quality of Life Measures in the Clinical Setting. BMJ, 322, 1297. https://doi.org/10.1136/bmj.322.7297.1297</mixed-citation></ref><ref id="scirp.96920-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Shah, A.M., Shah, R.B. and Kachoria, S. (2019) Health-Related Quality of Life and Associated Factors in Patients with Chronic Obstructive Pulmonary Disease. Drugs &amp; Therapy Perspectives, 35, 241-249. https://doi.org/10.1007/s40267-019-00617-9</mixed-citation></ref><ref id="scirp.96920-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Pati, S., Swain, S., Patel, S.K., Chauhan, A.S., Panda, N., Mahapatra, P. and Pati, S. (2018) An Assessment of Health-Related Quality of Life among Patients with Chronic Obstructive Pulmonary Diseases Attending a Tertiary Care Hospital in Bhubaneswar City, India. Journal of Family Medicine and Primary Care, 7, 1047-1053.</mixed-citation></ref><ref id="scirp.96920-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, K. and Joshi, S. (2015) Quality of Life of Patients with Chronic Obstructive Pulmonary Disease in Chitwan, Nepal: A Pilot Study Report. International Journal of Medical Science and Public Health, 4, 1235-1241. https://doi.org/10.5455/ijmsph.2015.25022015261</mixed-citation></ref><ref id="scirp.96920-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Cheruvu, V.K., Odhiambo, L.A., Mowls, D.S., Zullo, M.D. and Gudina, A.T. (2016) Health-Related Quality of Life in Current Smokers with COPD: Factors Associated with Current Smoking and New Insights into Sex Differences. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2211-2219. https://doi.org/10.2147/COPD.S106207</mixed-citation></ref><ref id="scirp.96920-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Joseph, S., Pascale, S., Georges, K. and Mirna, W. (2012) Cigarette and Waterpipe Smoking Decrease Respiratory Quality of Life in Adults: Results from a National Cross-Sectional Study. Pulmonary Medicine, 2012, Article ID: 868294. https://doi.org/10.1155/2012/868294</mixed-citation></ref><ref id="scirp.96920-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Wu, M., Zan, T., Zhao, Q., Ge, S., Li, K. and Li, J. (2019) Symptom Clusters and Health-Related Quality of Life in Chinese Patients with Chronic Obstructive Pulmonary Disease. Western Journal of Nursing Research. https://doi.org/10.1177/0193945919866475</mixed-citation></ref><ref id="scirp.96920-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Dignani, L., Toccaceli, A., Lucertini, C., Petrucci, C. and Lancia, L. (2016) Sleep and Quality of Life in People with COPD: A Descriptive-Correlational Study. Clinical Nursing Research, 25, 432-447. https://doi.org/10.1177/1054773815588515</mixed-citation></ref><ref id="scirp.96920-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Miravitlles, M., Molina, J., Naberan, K., Cots, J.M., Ros, F. and Llor, C. (2007) Factors Determining the Quality of Life of Patients with COPD in Primary Care. Therapeutic Advances in Respiratory Disease, 1, 85-92. https://doi.org/10.1177/1753465807086097</mixed-citation></ref><ref id="scirp.96920-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Bentsen, S.B., Miaskowski, C. and Rust&amp;#248;en, T. (2014) Demographic and Clinical Characteristics Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease. Quality of Life Research, 23, 991-998. https://doi.org/10.1007/s11136-013-0515-5</mixed-citation></ref><ref id="scirp.96920-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Negi, H., Sarkar, M., Raval, A., Pandey, K. and Das, P. (2014) Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in North India. Journal of Postgraduate Medicine, 60, 7-11. https://doi.org/10.4103/0022-3859.128797</mixed-citation></ref><ref id="scirp.96920-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Xiang, Y.T., Wong, T.S., Tsoh, J., Ungvari, G.S., Correll, C.U., Sareen, J., Chiu, H.F. (2015) Quality of Life in Older Patients with Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study. Perspectives in Psychiatric Care, 51, 121-127. https://doi.org/10.1111/ppc.12073</mixed-citation></ref><ref id="scirp.96920-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Raherison, C., Tillie-Leblond, I., Prudhomme, A., Taillé, C., Biron, E., Nocent-Ejnaini, C. and Ostinelli, J. (2014) Clinical Characteristics and Quality of Life in Women with COPD: An Observational Study. BMC Women’s Health, 14, Article No. 31. https://doi.org/10.1186/1472-6874-14-31</mixed-citation></ref><ref id="scirp.96920-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Bentsen, S.B., Rokne, B. and Wahl, A.K. (2013) Comparison of Health-Related Quality of Life between Patients with Chronic Obstructive Pulmonary Disease and the General Population. Scandinavian Journal of Caring Sciences, 27, 905-912. https://doi.org/10.1111/scs.12002</mixed-citation></ref><ref id="scirp.96920-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Bonsaksen, T., Haukeland-Parker, S., Lerdal, A. and Fagermoen, M.S. (2014) A 1-Year Follow-Up Study Exploring the Associations between Perception of Illness and Health-Related Quality of Life in Persons with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 9, 41-50. https://doi.org/10.2147/COPD.S52700</mixed-citation></ref><ref id="scirp.96920-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Vos, T., Abajobir, A.A., Abate, K.H., Abbafati, C., Abbas, K.M., Abd-Allah, F. and Murray, C.J.L. (2017) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1211-1259. https://doi.org/10.1016/S0140-6736(17)32154-2</mixed-citation></ref><ref id="scirp.96920-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Wytrychiewicz, K., Pankowski, D., Janowski, K., Bargiel-Matusiewicz, K., D&amp;#261;browski, J. and Fal, A.M. (2019) Smoking Status, Body Mass Index, Health-Related Quality of Life, and Acceptance of Life with Illness in Stable Outpatients with COPD. Frontiers in Psychology, 10, 1526. https://doi.org/10.3389/fpsyg.2019.01526</mixed-citation></ref><ref id="scirp.96920-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Ghilley, V.P., Bhadoria, D.P. and Pandit, S. (2018) Correntional Study of the Health-Related Quality of Life, Chronic Obstructive Airway Disease in Northern India, New Delhi. International Journal of Advances in Medicine, 5, 705-709. https://doi.org/10.18203/2349-3933.ijam20182127</mixed-citation></ref><ref id="scirp.96920-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Gaude, N.C. and Desai, A.M. (2018) Health Related Quality of Life in COPD Patients: A Cross-Sectional Study. International Journal of Community Medicine and Public Health, 5, 2038-2042. https://doi.org/10.18203/2394-6040.ijcmph20181719</mixed-citation></ref><ref id="scirp.96920-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Sundh, J., St&amp;#228;llberg, B., Lisspers, K., Montgomery, S.M. and Janson, C. (2011) Comorbidity, Body Mass Index and Quality of Life in COPD Using the Clinical COPD Questionnaire. COPD: Journal of Chronic Obstructive Pulmonary Disease, 8, 173-181. https://doi.org/10.3109/15412555.2011.560130</mixed-citation></ref><ref id="scirp.96920-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Obaseki, D.O., Erhabor, G.E., Awopeju, O.F., Obaseki, J.E. and Adewole, O.O. (2013) Determinants of Health Related Quality of Life in a Sample of Patients with Chronic Obstructive Pulmonary Disease in Nigeria Using the St. George’s Respiratory Questionnaire. African Health Sciences, 13, 694-702. https://doi.org/10.4314/ahs.v13i3.25</mixed-citation></ref><ref id="scirp.96920-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Lee, H., Jhun, B.W., Cho, J., Yoo, K.H., Lee, J.H., Kim, D.K. and Park, H.Y. (2017) Different Impacts of Respiratory Symptoms and Comorbidities on COPD-Specific Health-Related Quality of Life by COPD Severity. International Journal of Chronic Obstructive Pulmonary Disease, 12, 3301-3310. https://doi.org/10.2147/COPD.S145910</mixed-citation></ref><ref id="scirp.96920-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Han, M.K., Curran-Everett, D., Dransfield, M.T., Criner, G.J., Zhang, L., Murphy, J.R. and Regan, E.A. (2011) Racial Differences in Quality of Life in Patients with COPD. Chest, 140, 1169-1176. https://doi.org/10.1378/chest.10-2869</mixed-citation></ref><ref id="scirp.96920-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Justine, M., Tahirah, F. and Mohan, V. (2013) Health-Related Quality of Life, Lung Function and Dyspnea Rating in COPD Patients. Monaldi Archives for Chest Disease, 79, 116-120. https://doi.org/10.4081/monaldi.2013.5209</mixed-citation></ref><ref id="scirp.96920-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Abu Hassan, H., Abd Aziz, N., Hassan, Y. and Hassan, F. (2014) Does the Duration of Smoking Cessation Have an Impact on Hospital Admission and Health-Related Quality of Life amongst COPD Patients? International Journal of Chronic Obstructive Pulmonary Disease, 9, 493-499. https://doi.org/10.2147/COPD.S56637</mixed-citation></ref><ref id="scirp.96920-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Das, S.K., Bam, N. and Ghimire, P. (2017) Health Related Quality of Life (HRQOL) Assessment Using St. George’s Respiratory Questionaire in Patients with Stable Chronic Obstructive Pulmonary Disease. Journal of Institute of Medicine, 29, 21-25.</mixed-citation></ref><ref id="scirp.96920-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Wijnhoven, H.A., Kriegsman, D.M., Hesselink, A.E., Penninx, B.W. and de Haan, M. (2001) Determinants of Different Dimensions of Disease Severity in Asthma and COPD: Pulmonary Function and Health-Related Quality of Life. Chest, 119, 1034-1042. https://doi.org/10.1378/chest.119.4.1034</mixed-citation></ref><ref id="scirp.96920-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Clancy, K., Hallet, C. and Caress, A. (2009) The Meaning of Living with Chronic Obstructive Pulmonary Disease. Journal of Nursing and Healthcare of Chronic Illness, 1, 78-86. https://doi.org/10.1111/j.1365-2702.2008.01005.x</mixed-citation></ref><ref id="scirp.96920-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Borge, C.R., Wahl, A.K. and Moum, T. (2010) Association of Breathlessness with Multiple Symptoms in Chronic Obstructive Pulmonary Disease. Journal of Advanced Nursing, 66, 2688-2700. https://doi.org/10.1111/j.1365-2648.2010.05447.x</mixed-citation></ref><ref id="scirp.96920-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Moy, M.L., Reilly, J.J., Ries, A.L., Mosenifar, Z., Kaplan, R.M., Lew, R. and Garshick, E. (2009) Multivariate Models of Determinants of Health-Related Quality of Life in Severe Chronic Obstructive Pulmonary Disease. Journal of Rehabilitation Research and Development, 46, 643-654. https://doi.org/10.1682/JRRD.2008.09.0127</mixed-citation></ref><ref id="scirp.96920-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Talley, C.H. and Wicks, M.N. (2009) A Pilot Study of the Self-Reported Quality of Life for Patients with Chronic Obstructive Pulmonary Disease. Heart &amp; Lung, 38, 141-150. https://doi.org/10.1016/j.hrtlng.2008.05.001</mixed-citation></ref><ref id="scirp.96920-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Stridsman, C., Lindberg, A. and Sk&amp;#228;r, L. (2014) Fatigue in Chronic Obstructive Pulmonary Disease: A Qualitative Study of People’s Experiences. Scandinavian Journal of Caring Sciences, 28, 130-138. https://doi.org/10.1111/scs.12033</mixed-citation></ref><ref id="scirp.96920-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Peters, J.B., Heijdra, Y.F., Daudey, L., Boer, L.M., Molema, J., Dekhuijzen, P.R. and Vercoulen, J.H. (2011) Course of Normal and Abnormal Fatigue in Patients with Chronic Obstructive Pulmonary Disease, and Its Relationship with Domains of Health Status. Patient Education and Counseling, 85, 281-285. https://doi.org/10.1016/j.pec.2010.08.021</mixed-citation></ref><ref id="scirp.96920-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Blinderman, C.D., Homel, P., Billings, J.A., Tennstedt, S. and Portenoy, R.K. (2009) Symptom Distress and Quality of Life in Patients with Advanced Chronic Obstructive Pulmonary Disease. Journal of Pain and Symptom Management, 38, 115-123. https://doi.org/10.1016/j.jpainsymman.2008.07.006</mixed-citation></ref><ref id="scirp.96920-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Randazzo, V.P. (2015) Anxiety, Depression, Loneliness, Spirituality, and Disease Exacerbation in COPD Patients. Azusa Pacific University, Azusa.</mixed-citation></ref><ref id="scirp.96920-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Livermore, N., Sharpe, L. and McKenzie, D. (2010) Prevention of Panic Attacks and Panic Disorder in COPD. European Respiratory Journal, 35, 557-563. https://doi.org/10.1183/09031936.00060309</mixed-citation></ref><ref id="scirp.96920-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Chen, Y.W., Camp, P.G., Coxson, H.O., Road, J.D., Guenette, J.A., Hunt, M.A. and Reid, W. D. (2018) A Comparison of Pain, Fatigue, Dyspnea and Their Impact on Quality of Life in Pulmonary Rehabilitation Participants with Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease, 15, 65-72. https://doi.org/10.1080/15412555.2017.1401990</mixed-citation></ref><ref id="scirp.96920-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Lim, K.E., Kim, S.R., Kim, H.K. and Kim, S.R. (2017) Symptom Clusters and Quality of Life in Subjects with COPD. Respiratory Care, 62, 1203-1211. https://doi.org/10.4187/respcare.05374</mixed-citation></ref><ref id="scirp.96920-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Stridsman, C., Svensson, M., Johansson Strandkvist, V., Hedman, L., Backman, H. and Lindberg, A. (2018) The COPD Assessment Test (CAT) Can Screen for Fatigue among Patients with COPD. Therapeutic Advances in Respiratory Disease, 12. https://doi.org/10.1177/1753466618787380</mixed-citation></ref><ref id="scirp.96920-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Baltzan, M.A., Scott, A.S., Wolkove, N., Bailes, S., Bernard, S., Bourbeau, J. and Maltais, F. (2011) Fatigue in COPD: Prevalence and Effect on Outcomes in Pulmonary Rehabilitation. Chronic Respiratory Disease, 8, 119-128. https://doi.org/10.1177/1479972310396737</mixed-citation></ref><ref id="scirp.96920-ref62"><label>62</label><mixed-citation publication-type="other" xlink:type="simple">Mewes, R., Rief, W., Kenn, K., Ried, J. and Stenzel, N. (2016) Psychological Predictors for Health-Related Quality of Life and Disability in Persons with Chronic Obstructive Pulmonary Disease (COPD). Psychology &amp; Health, 31, 470-486. https://doi.org/10.1080/08870446.2015.1111369</mixed-citation></ref><ref id="scirp.96920-ref63"><label>63</label><mixed-citation publication-type="other" xlink:type="simple">Martinez, C.H., Diaz, A.A., Parulekar, A.D., Rennard, S.I., Kanner, R.E., Hansel, N.N. and Curtis, J.L. (2016) Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest, 149, 927-935. https://doi.org/10.1016/j.chest.2015.11.025</mixed-citation></ref><ref id="scirp.96920-ref64"><label>64</label><mixed-citation publication-type="other" xlink:type="simple">Pascal, O.I., Trofor, A.C., Lotrean, L.M., Filipeanu, D. and Trofor, L. (2017) Depression, Anxiety and Panic Disorders in Chronic Obstructive Pulmonary Disease Patients: Correlations with Tobacco Use, Disease Severity and Quality of Life. Tobacco Induced Diseases, 15, 23. https://doi.org/10.1186/s12971-017-0128-9</mixed-citation></ref><ref id="scirp.96920-ref65"><label>65</label><mixed-citation publication-type="other" xlink:type="simple">Balcells, E., Gea, J., Ferrer, J., Serra, I., Orozco-Levi, M., de Batlle, J. and Garcia-Aymerich, J. (2010) Factors Affecting the Relationship between Psychological Status and Quality of Life in COPD Patients. Health and Quality of Life Outcomes, 8, Article No. 108. https://doi.org/10.1186/1477-7525-8-108</mixed-citation></ref><ref id="scirp.96920-ref66"><label>66</label><mixed-citation publication-type="other" xlink:type="simple">Al-Gamal, E. (2014) Quality of Life, Anxiety and Depression among Patients with Chronic Obstructive Pulmonary Disease and Their Spouses. Issues in Mental Health Nursing, 35, 761-767. https://doi.org/10.3109/01612840.2014.908440</mixed-citation></ref><ref id="scirp.96920-ref67"><label>67</label><mixed-citation publication-type="other" xlink:type="simple">Mehta, J.R., Ratnani, I.J., Dave, J.D., Panchal, B.N., Patel, A.K. and Vala, A.U. (2014) Association of Psychiatric Co-Morbidities and Quality of Life with Severity of Chronic Obstructive Pulmonary Disease. East Asian Archives of Psychiatry, 24, 148-155.</mixed-citation></ref><ref id="scirp.96920-ref68"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">Hoth, K.F., Wamboldt, F.S., Strand, M., Ford, D.W., Sandhaus, R.A., Strange, C. and Holm, K.E. (2013) Prospective Impact of Illness Uncertainty on Outcomes in Chronic Lung Disease. Health Psychology, 32, 1170-1174. https://doi.org/10.1037/a0032721</mixed-citation></ref><ref id="scirp.96920-ref69"><label>69</label><mixed-citation publication-type="other" xlink:type="simple">Lou, P., Zhu, Y., Chen, P., Zhang, P., Yu, J., Zhang, N. and Zhao, J. (2012) Prevalence and Correlations with Depression, Anxiety, and Other Features in Outpatients with Chronic Obstructive Pulmonary Disease in China: A Cross-Sectional Case Control Study. BMC Pulmonary Medicine, 12, Article No. 53. https://doi.org/10.1186/1471-2466-12-53</mixed-citation></ref><ref id="scirp.96920-ref70"><label>70</label><mixed-citation publication-type="other" xlink:type="simple">Miyazaki, M., Nakamura, H., Chubachi, S., Sasaki, M., Haraguchi, M., Yoshida, S. and Minematsu, N. (2014) Analysis of Comorbid Factors That Increase the COPD Assessment Test Scores. Respiratory Research, 15, Article No. 13. https://doi.org/10.1186/1465-9921-15-13</mixed-citation></ref><ref id="scirp.96920-ref71"><label>71</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, X. and He, G. (2012) Effects of an Uncertainty Management Intervention on Uncertainty, Anxiety, Depression, and Quality of Life of Chronic Obstructive Pulmonary Disease Outpatients. Research in Nursing &amp; Health, 35, 409-418. https://doi.org/10.1002/nur.21483</mixed-citation></ref><ref id="scirp.96920-ref72"><label>72</label><mixed-citation publication-type="other" xlink:type="simple">Ivziku, D., Clari, M., Piredda, M., De Marinis, M.G. and Matarese, M. (2019) Anxiety, Depression and Quality of Life in Chronic Obstructive Pulmonary Disease Patients and Caregivers: An Actor-Partner Interdependence Model Analysis. Quality of Life Research, 28, 461-472. https://doi.org/10.1007/s11136-018-2024-z</mixed-citation></ref><ref id="scirp.96920-ref73"><label>73</label><mixed-citation publication-type="other" xlink:type="simple">Mishel, M.H. (1997) Uncertainty in Acute Illness. Annual Review of Nursing Research, 15, 57-80. https://doi.org/10.1891/0739-6686.15.1.57</mixed-citation></ref><ref id="scirp.96920-ref74"><label>74</label><mixed-citation publication-type="other" xlink:type="simple">Subih, M., Al-Kalaldeh, M., Salami, I., Al-Hadid, L. and Abu-Sharour, L. (2018) Predictors of Uncertainty among Postdischarge Coronary Artery Bypass Graft Patients in Jordan. Journal of Vascular Nursing, 36, 85-90. https://doi.org/10.1016/j.jvn.2017.11.001</mixed-citation></ref><ref id="scirp.96920-ref75"><label>75</label><mixed-citation publication-type="other" xlink:type="simple">Small, S. and Graydon, J. (1992) Perceived Uncertainty, Physical Symptoms, and Negative Mood in Hospitalized Patients with Chronic Obstructive Pulmonary Disease. Heart &amp; Lung, 21, 568-574.</mixed-citation></ref><ref id="scirp.96920-ref76"><label>76</label><mixed-citation publication-type="other" xlink:type="simple">Small, S.P. and Graydon, J.E. (1993) Uncertainty in Hospitalized Patients with Chronic Obstructive Pulmonary Disease. International Journal of Nursing Studies, 30, 239-246. https://doi.org/10.1016/0020-7489(93)90034-R</mixed-citation></ref><ref id="scirp.96920-ref77"><label>77</label><mixed-citation publication-type="other" xlink:type="simple">Mallouli, M., Dardouri, M., Ajmi, T., Mtiraoui, A., Ben Dhiab, M. and Zedini, C. (2017) Factors Determining the Quality of Life of Patients with COPD: A Review. Clinical Pulmonary Medicine, 24, 227-231. https://doi.org/10.1097/CPM.0000000000000222</mixed-citation></ref></ref-list></back></article>